Professor Trisha Peel (MBBShons, FRACP, GradCertClinRes, PhD) is an NHMRC L1 Fellow and Deputy Director (Research) in the Department of Infectious Diseases, Monash University and Alfred Health. She leads the Antimicrobial Stewardship Services at Epworth and Alfred Healthcare.  She was awarded her PhD in September 2013 and completed her post-doctoral fellowship at the Mayo Clinic, USA.

Her pioneering research focuses on antimicrobial resistance, infection prevention, and optimizing surgical infection management. She has led groundbreaking clinical trials, including the award-winning ASAP Trial and the CALIPSO Trial, which have set new standards for surgical infection care globally.

Professor Peel has secured substantial competitive grants to support her innovative work, contributing to advancements in infection prevention strategies and antimicrobial stewardship. Her research findings have informed national and international guidelines, shaping global health policy.

Beyond her research, Professor Peel is committed to translating evidence into practice. Her patient-centered approach involves co-designing infection prevention strategies with consumers, ensuring that her work delivers tangible benefits to healthcare systems and patients.

Her excellence in research, global collaborations, and mentorship have been recognized with prestigious awards, including the ACTA Trial of the Year. Professor Peel continues to drive impactful research initiatives that transform the field of infectious diseases and improve patient outcomes worldwide.

The Surgical Infection Research Group, led by Professor Trisha Peel, conducts large-scale clinical trials and implementation science research to develop and optimize strategies for preventing surgical site infections (SSIs). The group's primary objectives are:
a) to prevent the occurrence of SSIs by integrating cutting-edge microbiology, genomics, and innovative clinical trials; and
b) to minimize harm and curb the emergence of antimicrobial resistance in surgical patients.

This research spans the entire translational pathway, from bench to bedside, through to practice-based research and policy development. By advancing understanding of SSI development, prevention, and the responsible, evidence-based use of antimicrobials, the group aims to enhance patient outcomes and shape best practices in surgical care